Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05945602
What this trial is testing

Neurophysiologic Biomarkers for Cognitive Rehabilitation

Who this might be right for
Schizophrenia Spectrum Disorders
VA Office of Research and Development 80
Not applicableStudy completedNCT00832845
What this trial is testing

Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study

Who this might be right for
Schizophrenia
Centre for Addiction and Mental Health 80
Not applicableNot Yet RecruitingNCT07604129
What this trial is testing

Transcranial Sonography and Machine Learning for Schizophrenia Identification

Who this might be right for
Schizophrenia
Taizhou Second People's Hospital 200
Not applicableUnknownNCT00627029
What this trial is testing

Evaluation of Programs of Coordinated Care and Disease Management

Who this might be right for
Congestive Heart FailureDiabetesCoronary Artery Disease+6 more
Mathematica Policy Research, Inc. 18,277
Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Large-scale testing (Phase 3)Study completedNCT01561898
What this trial is testing

A Long-Term Study of JNS007ER in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Pharmaceutical K.K. 228
Post-approval studies (Phase 4)UnknownNCT02049021
What this trial is testing

Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia

Who this might be right for
Refractory SchizophreniaSuper Refractory Schizophrenia
University of Sao Paulo 20
Not applicableLooking for participantsNCT07419321
What this trial is testing

Social Isolation and Aging in Schizophrenia

Who this might be right for
Schizophrenia and Related Disorders
Icahn School of Medicine at Mount Sinai 650
Post-approval studies (Phase 4)Study completedNCT01136772
What this trial is testing

A Comparison of Long-acting Injectable Medications for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute 311
Not applicableStudy completedNCT03740139
What this trial is testing

The Police-Mental Health Linkage System

Who this might be right for
Mental Disorders, SevereSchizophrenia and Related DisordersBipolar Disorder+1 more
Columbia University 1,405
Post-approval studies (Phase 4)Study completedNCT04940039
What this trial is testing

Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 93
Large-scale testing (Phase 3)Study completedNCT00523445
What this trial is testing

The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Inje University 120
Not applicableStudy completedNCT02006862
What this trial is testing

EVAluatIon of OLanzapine TreatmEnT

Who this might be right for
Bipolar DisorderSchizophrenia
Elpen Pharmaceutical Co. Inc. 468
Large-scale testing (Phase 3)Study completedNCT00034762
What this trial is testing

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer DiseaseMental Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Not applicableStudy completedNCT05345977
What this trial is testing

EMotiph: E-mental Health Solution for Patients With Schizophrenia

Who this might be right for
Schizophrenia
Grupo Pulso 7
Testing effectiveness (Phase 2)Study completedNCT01400477
What this trial is testing

Nicotinic Receptors and Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Colorado, Denver 97
Not applicableEnded earlyNCT06134661
What this trial is testing

Accelerated rTMS for Psychomotor Slowing

Who this might be right for
Schizophrenia; PsychosisSchizophrenia and Related DisordersSchizo Affective Disorder+1 more
University of Bern 25
Post-approval studies (Phase 4)Study completedNCT00203788
What this trial is testing

Improving Work Outcome in People With Recent-onset Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 87
Not applicableStudy completedNCT03537703
What this trial is testing

Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia

Who this might be right for
Schizophrenia
VA Greater Los Angeles Healthcare System 35
Not applicableUnknownNCT04985786
What this trial is testing

Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and Schizophrenia

Who this might be right for
Alcohol Use Disorder (AUD)Schizophrenia and Related Disorders
University of Konstanz 240
Next Page